Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma.
Efthimiou
Y
Y
Wilhelm Auerswald Atherosclerosis Research Group (ASF), Vienna.
Pirich
C
C
Stomatopoulos
J
J
O'Grady
J
J
Sinzinger
H
H
D016632:Apolipoprotein A-I / Q000378:metabolism; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D011464:Epoprostenol / Q000097:blood*; D006207:Half-Life; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood*; D016778:Malaria, Falciparum / Q000097:blood*; D016780:Malaria, Vivax / Q000097:blood*; D014280:Triglycerides / Q000097:blood
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D002784:Cholesterol; D011464:Epoprostenol